Study on Protein Receptor’s Role in IBD Supports Decision to Develop Blocking Therapy, OSE Says
News
A study that OSE Immunotherapeutics conducted on the role that a protein receptor plays in bowel disease supports its development of a treatment that blocks the receptor, the company reports. It designed OSE-127 ... Read more